Filing Details

Accession Number:
0001179110-13-010111
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-11 11:26:53
Reporting Period:
2013-06-07
Filing Date:
2013-06-11
Accepted Time:
2013-06-11 11:26:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1274057 Hospira Inc HSP Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1439368 Sumant Ramachandra C/O Hospira, Inc.
275 North Field Drive
Lake Forest IL 60045
Senior Vice President And Cso No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-06-07 23,702 $35.36 44,326 No 4 M Direct
Common Stock Disposition 2013-06-07 23,702 $35.69 20,624 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2013-06-07 23,702 $0.00 23,702 $35.36
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-06-07 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 271 Indirect See note.
Footnotes
  1. This transaction was made pursuant to a plan dated May 30, 2013 complying with Rule 10b5-1(c).
  2. The price listed is the average sales price. The actual sales prices for these shares ranged from $35.50 to $35.89. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or a security holder of the issuer.
  3. Balance in the Hospira stock retirement plan as of June 7, 2013.
  4. These options were fully vested.